AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 263: E703-E711, 1992;
0193-1849/92 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lang, C. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lang, C. H.

AJP - Endocrinology and Metabolism, Vol 263, Issue 4 E703-E711, Copyright © 1992 by American Physiological Society


ARTICLES

Sepsis-induced insulin resistance in rats is mediated by a beta-adrenergic mechanism

C. H. Lang
Department of Physiology, Louisiana State University Medical Center, New Orleans 70112.

Bacterial infection decreases insulin-mediated glucose uptake (IMGU) by skeletal muscle and produces whole body insulin resistance. Because circulating catecholamines are elevated by the septic insult, the present study was performed to determine the potential role of the beta-adrenergic system in eliciting these changes. Before induction of sepsis, an infusion containing saline, propranolol, or atenolol was started and continued throughout the experimental protocol. Sepsis increased the basal rate of glucose production and utilization and impaired IMGU by peripheral tissues. The peripheral insulin resistance in septic rats was manifested by an increase in the dose producing 50% of maximal response and a decrease in the maximal responsiveness. Infusion of propranolol, a nonselective beta-adrenergic antagonist, attenuated the sepsis-induced increase in basal glucose turnover by 70% and completely prevented the decrease in IMGU by the whole body. In contrast, atenolol, a selective beta 1-antagonist, did not alter the glucose metabolic response to infection. Under basal conditions, propranolol prevented or attenuated the increase in glucose uptake by the gastrocnemius, diaphragm, skin, liver, lung, spleen, and ileum normally observed in septic rats. In addition, propranolol prevented the decrease in IMGU by various muscles and skin in septic animals. These results suggest that adrenergic stimulation, probably mediated by a beta 2-adrenergic mechanism, is partially responsible for the sepsis-induced increases in basal whole body glucose turnover and plays a prominent role in the development of peripheral insulin resistance in this condition.


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. A. Frost, G. J. Nystrom, and C. H. Lang
Epinephrine stimulates IL-6 expression in skeletal muscle and C2C12 myoblasts: role of c-Jun NH2-terminal kinase and histone deacetylase activity
Am J Physiol Endocrinol Metab, May 1, 2004; 286(5): E809 - E817.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S.-S. Chen, C. M. Donmoyer, D. A. Pearson, A. Poole, Y. Zhang, D. B. Lacy, and O. P. McGuinness
Impact of infection on glucose-dependent liver glucose uptake during TPN: interaction with insulin
Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E286 - E295.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. Sugita, M. Kaneki, E. Tokunaga, M. Sugita, C. Koike, S. Yasuhara, R. G. Tompkins, and J. A. J. Martyn
Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance
Am J Physiol Endocrinol Metab, February 1, 2002; 282(2): E386 - E394.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. M. Donmoyer, S.-S. Chen, S. A. Hande, D. B. Lacy, J. Ejiofor, and O. P. McGuinness
Hyperinsulinemia compensates for infection-induced impairment in net hepatic glucose uptake during TPN
Am J Physiol Endocrinol Metab, August 1, 2000; 279(2): E235 - E243.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. C. Lekas, S. J. Fisher, B. El-Bahrani, M. van Delangeryt, M. Vranic, and Z. Q. Shi
Glucose uptake during centrally induced stress is insulin independent and enhanced by adrenergic blockade
J Appl Physiol, August 1, 1999; 87(2): 722 - 731.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
O. P. McGuinness, C. Donmoyer, J. Ejiofor, S. McElligott, and D. B. Lacy
Hepatic and muscle glucose metabolism during total parenteral nutrition: impact of infection
Am J Physiol Endocrinol Metab, November 1, 1998; 275(5): E763 - E769.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
G. H. Crist, B. Xu, K. F. Lanoue, and C. H. Lang
Tissue-specific effects of in vivo adenosine receptor blockade on glucose uptake in Zucker rats
FASEB J, October 1, 1998; 12(13): 1301 - 1308.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
O. P. McGuinness, V. Shau, E. M. Benson, M. Lewis, R. T. Snowden, J. E. Greene, D. W. Neal, and A. D. Cherrington
Role of epinephrine and norepinephrine in the metabolic response to stress hormone infusion in the conscious dog
Am J Physiol Endocrinol Metab, October 1, 1997; 273(4): E674 - E681.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online